Literature DB >> 34789475

Terlipressin: Hopes Fulfilled or Dashed?

Raimund H Pichler1, Erik R Swenson2,3, Peter J Leary2, Cary H Paine4.   

Abstract

Entities:  

Keywords:  HRS-AKI; hepatorenal syndrome; norepinephrine; pulmonary edema; respiratory failure; terlipressin

Mesh：

Substances：

Year:  2021        PMID： 34789475      PMCID： PMC8763145          DOI： 10.2215/CJN.06710521

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Characterization of vasopressin receptor in rat lung.

Authors:  A Tahara; Y Tomura; K Wada; T Kusayama; J Tsukada; N Ishii; T Yatsu; W Uchida; A Tanaka
Journal:  Neuropeptides       Date:  1998-06       Impact factor: 3.286

2.  Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.

Authors:  Thomas D Boyer; Arun J Sanyal; Florence Wong; R Todd Frederick; John R Lake; Jacqueline G O'Leary; Daniel Ganger; Khurram Jamil; Stephen Chris Pappas
Journal:  Gastroenterology       Date:  2016-02-16       Impact factor: 22.682

3.  Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

Authors:  Florence Wong; S Chris Pappas; Michael P Curry; K Rajender Reddy; Raymond A Rubin; Michael K Porayko; Stevan A Gonzalez; Khalid Mumtaz; Nicholas Lim; Douglas A Simonetto; Pratima Sharma; Arun J Sanyal; Marlyn J Mayo; R Todd Frederick; Shannon Escalante; Khurram Jamil
Journal:  N Engl J Med       Date:  2021-03-04       Impact factor: 91.245

4.  Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome.

Authors:  Allison Kwong; W Ray Kim; Paul Y Kwo; Uerica Wang; Xingxing Cheng
Journal:  Liver Transpl       Date:  2021-04-10       Impact factor: 5.799

5.  Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.

Authors:  Vinod Arora; Rakhi Maiwall; Vijayaraghavan Rajan; Ankur Jindal; Saggere Muralikrishna Shasthry; Guresh Kumar; Priyanka Jain; Shiv Kumar Sarin
Journal:  Hepatology       Date:  2019-02-20       Impact factor: 17.425

6.  Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

Authors:  Marta Martín-Llahí; Marie-Noëlle Pépin; Mónica Guevara; Fernando Díaz; Aldo Torre; Alberto Monescillo; Germán Soriano; Carlos Terra; Emilio Fábrega; Vicente Arroyo; Juan Rodés; Pere Ginès
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

7.  A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

Authors:  Arun J Sanyal; Thomas Boyer; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Andres Blei; Veit Gülberg; Samuel Sigal; Peter Teuber
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

8.  Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide.

Authors:  P R Evora; P J Pearson; H V Schaff
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

9.  Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis.

Authors:  Ernesto Lopez; Satoshi Fukuda; Katalin Modis; Osamu Fujiwara; Baigal Enkhtaivan; Raul Trujillo-Abarca; Koji Ihara; Francisco Lima-Lopez; Dannelys Perez-Bello; Csaba Szabo; Donald S Prough; Perenlei Enkhbaatar
Journal:  Pharmacol Res       Date:  2020-11-04       Impact factor: 7.658

10.  Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices.

Authors:  Annette D Rieg; Rolf Rossaint; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.